Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Finkelmeier

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Annals of Hematology|July 25, 2021
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapyOlivier Ballo, Fagr Eladly, Sebastian Koschade, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2023
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary centerMaximilian N Kinzler, Jan Jeroch, Christina Klasen, et al.
Plos One|July 17, 2018
Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosisFabian Finkelmeier, Özge Canli, Kai-Henrik Peiffer, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2021
Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinomaVera Himmelsbach, Mate Knabe, Phillip G Ferstl, et al.
JHEP Reports : Innovation in Hepatology|February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failureChristiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
The Lancet. Gastroenterology & Hepatology|February 20, 2026
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose studyFrank Erhard Uschner, Martin McCoy, Olaf Tyc, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2021
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infectionMichael Basic, Alica Kubesch, Lisa Kuhnhenn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2024
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary processMichael Basic, Keerthihan Thiyagarajah, Mirco Glitscher, et al.
Histopathology|February 27, 2024
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinomaMaximilian N Kinzler, Falko Schulze, Jan Jeroch, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Annals of Hematology|July 25, 2021
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapyOlivier Ballo, Fagr Eladly, Sebastian Koschade, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2023
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary centerMaximilian N Kinzler, Jan Jeroch, Christina Klasen, et al.
Plos One|July 17, 2018
Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosisFabian Finkelmeier, Özge Canli, Kai-Henrik Peiffer, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2021
Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinomaVera Himmelsbach, Mate Knabe, Phillip G Ferstl, et al.
JHEP Reports : Innovation in Hepatology|February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failureChristiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
The Lancet. Gastroenterology & Hepatology|February 20, 2026
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose studyFrank Erhard Uschner, Martin McCoy, Olaf Tyc, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2021
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infectionMichael Basic, Alica Kubesch, Lisa Kuhnhenn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2024
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary processMichael Basic, Keerthihan Thiyagarajah, Mirco Glitscher, et al.
Histopathology|February 27, 2024
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinomaMaximilian N Kinzler, Falko Schulze, Jan Jeroch, et al.
Pageof 13